An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice

Journal of Bone and Mineral Research

Volumn 28, Issue 10, 2013, Pages 2064-2069

  Takarada, Takeshi ^a   Hinoi, Eiichi ^a   Nakazato, Ryota ^a   Ochi, Hiroki ^b,c   Xu, Cheng ^b   Tsuchikane, Azusa ^a   Takeda, Shu ^b   Karsenty, Gerard ^d   Abe, Takaya ^e   Kiyonari, Hiroshi ^e   Yoneda, Yukio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^d Columbia University ^*  (United States)

^e RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

chondrocyte; conditional knockout; osteoblast; Runx2; skeletogenesis

Indexed keywords

ALCIAN BLUE; ALIZARIN; ALIZARIN RED S; COLLAGEN; TRANSCRIPTION FACTOR RUNX2;

ALLELE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CARTILAGE CELL; CARTILAGE MATRIX; EMBRYO; ENCHONDRAL OSSIFICATION; EXON; LONG BONE; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; SKELETON MALFORMATION; VERTEBRA;

CHONDROCYTE; CONDITIONAL KNOCKOUT; OSTEOBLAST; RUNX2; SKELETOGENESIS;

ANIMALS; BONE DEVELOPMENT; CHONDROCYTES; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; INTEGRASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; PHENOTYPE;

EID: 84884521604     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1945     Document Type: Article

References (19)

1. Karsenty G., The complexities of skeletal biology. Nature. 2003; 423: 316-8.
2. Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Hecht J, Geoffroy V, Ducy P, Karsenty G., Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet. 1997; 16: 307-10.
3. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR., Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 1997; 89: 773-9.
4. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G., Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997; 89: 747-54.
5. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T., Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997; 89: 755-64.
6. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ., Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1197; 89: 765-71.
7. Maruyama Z, Yoshida CA, Furuichi T, Amizuka N, Ito M, Fukuyama R, Miyazaki T, Kitaura H, Nakamura K, Fujita T, Kanatani N, Moriishi T, Yamana K, Liu W, Kawaguchi H, Nakamura K, Komori T., Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev Dyn. 2007; 236: 1876-90.
8. Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, Himeno M, Narai S, Yamaguchi A, Komori T., Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol. 2001; 155: 157-66.
9. Ueta C, Iwamoto M, Kanatani N, Yoshida C, Liu Y, Enomoto-Iwamoto M, Ohmori T, Enomoto H, Nakata K, Takada K, Kurisu K, Komori T., Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J Cell Biol. 2001; 153: 87-100.
10. Chen H, Ghori-Javed FY, Rashid H, Serra R, Gutierrez SE, Javed A., Chondrocyte-specific regulatory activity of Runx2 is essential for survival and skeletal development. Cells Tissues Organs. 2011; 194: 161-5.
11. Yagi T, Tokunaga T, Furuta Y, Nada S, Yoshida M, Tsukada T, Saga Y, Takeda N, Ikawa Y, Aizawa S., A novel ES cell line, TT2, with high germline-differentiating potency. Anal Biochem. 1993; 214: 70-6.
12. Dacquin R, Starbuck M, Schinke T, Karsenty G., Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev Dyn. 2002; 224: 245-51.
13. Terpstra L, Prud'homme J, Arabian A, Takeda S, Karsenty G, Dedhar S, St-Arnaud R., Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes. J Cell Biol. 2003; 162: 139-48.
14. Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, Karsenty G., ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell. 2004; 117: 387-98.
15. Lefebvre V, Garofalo S, Zhou G, Metsaranta M, Vuorio E, De Crombrugghe B., Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol. 1994; 14: 329-35.
16. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR., Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2: 595-610.
17. Fujita K, Iwasaki M, Ochi H, Fukuda T, Ma C, Miyamoto T, Takitani K, Negishi-Koga T, Sunamura S, Kodama T, Takayanagi H, Tamai H, Kato S, Arai H, Shinomiya K, Itoh H, Okawa A, Takeda S., Vitamin E decreases bone mass by stimulating osteoclast fusion. Nat Med. 2012; 18: 589-94.
18. Aubin JE, Triffitt JT., Mesenchymal stem cells and osteoblast differentiation. In:, Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. New York: Academic Press; 2002. p. 59-81.
19. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G., A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 1999; 13: 1025-36. Technology